Lexaria Bioscience LEXX
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2026Q1 | 11.7 | 5 | -35.11 | -2 | -35.34 | 5 |
| 2025Q4 | 9.26 | 7 | -25.18 | -1 | -23.13 | 6 |
| 2025Q3 | 14.29 | 5 | -40.36 | -2 | -31.19 | 6 |
| 2025Q2 | 13.05 | 3 | -63.12 | -3 | -49.4 | 4 |
| 2025Q1 | 25.65 | 6 | -59.68 | -4 | -49.15 | 7 |
| 2024Q4 | 31.5 | 7 | -32.07 | -3 | -29.37 | 9 |
| 2024Q3 | 45.75 | 10 | -30.36 | -3 | -28.98 | 10 |
| 2024Q2 | 41.7 | 8 | -24.07 | -2 | -23.14 | 9 |
| 2024Q1 | 54.45 | 10 | -21.41 | -2 | -21.77 | 10 |
| 2023Q4 | 18.75 | 7 | -12.67 | -1 | -13.03 | 6 |
| 2023Q3 | 15 | 4 | -36.72 | -1 | -35.14 | 4 |
| 2023Q2 | 10.95 | 3 | -34.6 | -1 | -30.92 | 3 |
| 2023Q1 | 40.8 | 4 | -51.42 | -2 | -47.73 | 5 |
| 2022Q4 | 36.9 | 5 | -23.1 | -1 | -23.46 | 5 |
| 2022Q3 | 36.75 | 6 | -24.71 | -2 | -25 | 6 |
| 2022Q2 | 44.7 | 8 | -17.66 | -2 | -17.83 | 8 |
| 2022Q1 | 49.5 | 9 | -23.43 | -2 | -23.53 | 9 |
| 2021Q4 | 60.45 | 11 | -12.53 | -1 | -12.51 | 11 |
| 2021Q3 | 93.9 | 12 | -16.06 | -2 | -16.02 | 12 |
| 2021Q2 | 105 | 13 | -11.04 | -1 | -10.94 | 13 |